Jamin Christian Georges, Häusler Gunther, Lobo Abascal Paloma, Fiala Christian, Lete Lasa Luis Ignacio, Nappi Rossella Elena, Micheletti Marie-Christine, Fernández-Dorado Ana, Pintiaux Axelle, Chabbert-Buffet Natalie
a 169, Boulevard Haussmann , Paris , France.
b Department of Gynaecology and Gynaecological Oncology , Vienna General Hospital , Vienna , Austria.
Eur J Contracept Reprod Health Care. 2017 Aug;22(4):286-290. doi: 10.1080/13625187.2017.1364719. Epub 2017 Sep 7.
The aim of this research was to develop a questionnaire to facilitate choice of the most appropriate contraceptive method for individual women.
A literature review was conducted to identify key aspects influencing contraceptive choice and inform development of a questionnaire for online completion. Questionnaire development was overseen by a steering committee consisting of eight gynaecologists from across Europe. The initial draft underwent conceptual validation through cognitive debriefing interviews with six native English-speaking women. A qualitative content analysis was conducted to accurately identify potential issues and areas for questionnaire improvement. A revised version of the questionnaire then underwent face-to-face and online evaluation by 115 international gynaecologists/obstetricians with expertise in contraception, prior to development of a final version.
The final conceptually validated Contraception: HeLping for wOmen's choicE (CHLOE) questionnaire takes ≤10 min to complete and includes three sections to elicit general information about the individual, the health conditions that might influence contraceptive choice, and the woman's needs and preferences that might influence contraceptive choice. The questionnaire captures the core aspects of personalisation, efficacy and safety, identified as key attributes influencing contraceptive choice, and consists of 24 closed-ended questions for online completion prior to a health care provider (HCP) consultation. The HCP receives a summary of the responses.
The CHLOE questionnaire has been developed to help women choose the contraception that best suits their needs and situation while optimising the HCP's time.
本研究旨在开发一份问卷，以帮助为个体女性选择最合适的避孕方法。
进行文献综述，以确定影响避孕选择的关键因素，并为在线填写问卷的开发提供参考。问卷开发由一个由来自欧洲各地的八名妇科医生组成的指导委员会监督。初始草案通过对六名以英语为母语的女性进行认知反馈访谈进行概念验证。进行定性内容分析，以准确识别潜在问题和问卷改进领域。在最终版本开发之前，问卷的修订版由115名在避孕方面具有专业知识的国际妇科医生/产科医生进行面对面和在线评估。
最终经过概念验证的避孕：帮助女性选择（CHLOE）问卷完成时间≤10分钟，包括三个部分，以获取有关个体的一般信息、可能影响避孕选择的健康状况以及可能影响避孕选择的女性需求和偏好。该问卷涵盖了个性化、有效性和安全性等核心方面，这些被确定为影响避孕选择的关键属性，由24个封闭式问题组成，用于在医疗保健提供者（HCP）咨询之前在线填写。HCP会收到回复摘要。
CHLOE问卷的开发旨在帮助女性选择最适合其需求和情况的避孕方法，同时优化HCP的时间。
